0001140361-22-009654.txt : 20220315
0001140361-22-009654.hdr.sgml : 20220315
20220315213025
ACCESSION NUMBER: 0001140361-22-009654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220311
FILED AS OF DATE: 20220315
DATE AS OF CHANGE: 20220315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Esfandiari Javan
CENTRAL INDEX KEY: 0001397402
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35569
FILM NUMBER: 22743137
MAIL ADDRESS:
STREET 1: 3661 HORSEBLOCK ROAD
CITY: MEDFORD
STATE: NY
ZIP: 11763
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC.
CENTRAL INDEX KEY: 0001092662
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880425691
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 555 WIRELESS BLVD.
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
BUSINESS PHONE: (631) 924-1135
MAIL ADDRESS:
STREET 1: 555 WIRELESS BLVD.
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
FORMER COMPANY:
FORMER CONFORMED NAME: Chembio Diagnostics Inc.
DATE OF NAME CHANGE: 20040607
FORMER COMPANY:
FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC
DATE OF NAME CHANGE: 19990805
4
1
form4.xml
FORM 4
X0306
4
2022-03-11
0001092662
CHEMBIO DIAGNOSTICS, INC.
CEMI
0001397402
Esfandiari Javan
C/O CHEMBIO DIAGNOSTICS, INC.
555 WIRELESS BOULEVARD
HAUPPAUGE
NY
11788
true
See Remarks
Restricted Stock Units
2021-03-11
4
A
0
144000
0
A
Common Stock
144000
144000
D
Incentive Stock Options
1.25
2021-03-11
4
A
0
69435
0
A
2032-03-10
Common Stock
69435
69435
D
Nonqualified Stock Options
1.25
2021-03-11
4
A
0
208279
0
A
2032-03-10
Common Stock
208281
208281
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
On March 16, 2020, the reporting person was granted 144,000 restricted stock units scheduled to vest in equal installments on March 11 of each of 2023, 2024 and 2025, subject to continued service through each vesting date.
The incentive stock options are scheduled to vest and become exercisable over four years, with two shares vesting on March 11, 2023, two shares vesting on March 11, 2024, two shares vesting on March 11, 2025 and the remaining 69,429 shares vesting on March 11, 2026, subject to continued service through each vesting date.
The nonqualified stock options are scheduled to vest and become exercisable over three years, with 69,426 shares vesting on March 11, 2023, 69,427 shares vesting on March 11, 2024, and 69,426 shares vesting on March 11, 2025, subject to continued service through each vesting date.
Executive Vice President, Chief Science and Technology Officer
/s/ Mark L. Johnson, Attorney-in-Fact for Javan Esfandiari
2022-03-15